IPO subscription report
Asset Reconstruction Company (India) Limited IPO — category-wise subscription
Final bidding figures by investor category with an arithmetic estimate of allotment odds. Share the card on WhatsApp or download it as an image.
VIA Capital • IPO subscription report
Asset Reconstruction Company (India) Limited
ARCIL • Mainboard • Latest captured figures
Issue dates
09 Sept 2026 – 11 Sept 2026
Price band
Rs.132 to Rs.139
Lot size
—
Total subscription
0.24x
Category-wise bidding
| Category | Times subscribed | Applications |
|---|---|---|
QIB Qualified Institutional Buyers — mutual funds, insurers, banks and FPIs. | 0.09x | — |
NII (Total) All non-institutional / HNI bids above ₹2 lakh. | 0.33x | — |
Retail (RII) Individual investors applying up to ₹2 lakh. | 0.56x | — |
| Total | 0.24x | — |
Total issue size
₹732.97 Cr
Shares offered
3.69 Cr shares
Shares bid for
—
Bids received (value)
—
Day-wise subscription
| Day | QIB | NII | Retail | Total | Applications |
|---|---|---|---|---|---|
Day 1 09 Sept 2026 | 0.09x | 0.33x | 0.56x | 0.24x | — |
Day 2 10 Sept 2026 | 0.09x | 0.33x | 0.56x | 0.24x | — |
Captured from the exchange feed once per bidding day. Days before this report was first captured are not available.
Estimated allotment chance
Retail (1 lot)
Full allotment likely (not oversubscribed)
1 lot • lottery basis
sNII (₹2–10 lakh)
Full allotment likely (not oversubscribed)
1 lot • lottery basis
bNII (Above ₹10 lakh)
Full allotment likely (not oversubscribed)
1 lot • proportionate basis
Educational information only. Subscription figures are sourced from exchange public data and allotment chances are arithmetic estimates from those figures — the binding allotment is the Basis of Allotment published by the registrar. VIA Capital does not provide investment advice or allotment guarantees. Read the RHP before investing. Source: NSE public market data. Captured 10/9/2026, 2:22:00 am.
Educational content only. VIA Capital does not provide buy/sell calls, tips, or personalized advice. Always do your own research.
